Team memberGC BiopharmaYongin, Kyonggi-do, Republic of Korea
OC 08.1 - GC1126A, a novel ADAMTS13 mutein that evades autoantibody as a superior therapy for acquired thrombotic thrombocytopenic purpura (aTTP)
Saturday, June 24, 202313:00 – 13:15 ET